BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 109 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $746,400 | -30.5% | 40,000 | -20.0% | 0.52% | -51.5% |
| Q4 2022 | $1,074,000 | +81.7% | 50,000 | 0.0% | 1.06% | +75.1% |
| Q3 2022 | $591,000 | -41.9% | 50,000 | 0.0% | 0.61% | +104.7% |
| Q4 2021 | $1,017,000 | -4.2% | 50,000 | +42.9% | 0.30% | +9.6% |
| Q3 2021 | $1,062,000 | +46.1% | 35,000 | +40.0% | 0.27% | +37.1% |
| Q2 2021 | $727,000 | -32.6% | 25,000 | 0.0% | 0.20% | -45.9% |
| Q1 2021 | $1,079,000 | -6.6% | 25,000 | 0.0% | 0.36% | -24.5% |
| Q4 2020 | $1,155,000 | +33.2% | 25,000 | +25.0% | 0.48% | +14.8% |
| Q3 2020 | $867,000 | -34.6% | 20,000 | -20.0% | 0.42% | -43.8% |
| Q2 2020 | $1,325,000 | – | 25,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
| Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
| Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
| Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
| Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
| PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
| AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |